Fosters Research
No Result
View All Result
No Result
View All Result
Fosters Research
No Result
View All Result
Home Industry

There’s Something Awry at Cohen & Steers Inc. (NYSE:CNS) Since Share Price Gets Ahead of Fundamentals

January 25, 2023
in Industry

The stock of Cohen & Steers Inc. (NYSE:CNS) last traded at $73.34, down -0.10% from the previous session.

Data from the available sources indicates that Cohen & Steers Inc. (NYSE:CNS) is covered by 2 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $71.00 and a low of $71.00, we find $71.00. Given the previous closing price of $73.41, this indicates a potential downside of -3.28 percent. CNS stock price is now 9.95% away from the 50-day moving average and 5.19% away from the 200-day moving average. The market capitalization of the company currently stands at $3.50B.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

In total, 0 analysts have assigned it a hold rating, and 1 have given it a buy rating. Brokers who have rated the stock have averaged $71.00 as their price target over the next twelve months.

With the price target maintained at $83, Sidoti recently Upgraded its rating from Neutral to Buy for Cohen & Steers Inc. (NYSE: CNS)., while ‘BofA Securities’ rates the stock as ‘Buy’.

In other news, COHEN MARTIN, Director sold 12,600 shares of the company’s stock on Aug 15. The stock was sold for $972,468 at an average price of $77.18. Upon completion of the transaction, the Director now directly owns 1,076,184 shares in the company, valued at $78.93 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 12, Director COHEN MARTIN sold 23,487 shares of the business’s stock. A total of $1,822,323 was realized by selling the stock at an average price of $77.59. This leaves the insider owning 1,088,784 shares of the company worth $79.85 million. Insiders disposed of 459,712 shares of company stock worth roughly $33.72 million over the past 1 year. A total of 7.30% of the company’s stock is owned by insiders.

There have been several recent changes in the stakes of large investors in CNS stock. A new stake in Cohen & Steers Inc. shares was purchased by CFS INVESTMENT ADVISORY SERVICES, LLC during the first quarter worth $9,673,000. STATE OF NEW JERSEY COMMON PENSION FUND D invested $2,339,000 in shares of CNS during the first quarter. In the first quarter, GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC acquired a new stake in Cohen & Steers Inc. valued at approximately $2,224,000. NATIXIS ADVISORS, L.P. acquired a new stake in CNS for approximately $999,000. MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. purchased a new stake in CNS valued at around $902,000 in the second quarter. In total, there are 303 active investors with 48.90% ownership of the company’s stock.

With an opening price of $73.77 on Tuesday morning, Cohen & Steers Inc. (NYSE: CNS) set off the trading day. During the past 12 months, Cohen & Steers Inc. has had a low of $52.34 and a high of $88.21. The fifty day moving average price for CNS is $66.70 and a two-hundred day moving average price translates $69.72 for the stock.

The latest earnings results from Cohen & Steers Inc. (NYSE: CNS) was released for Sep, 2022. According to the Asset Management Company, earnings per share came in at $0.92, beating analysts’ expectations of $0.86 by 0.06. This compares to $1.05 EPS in the same period last year. The net profit margin was 33.80% and return on equity was 72.80% for CNS. The company reported revenue of $139.95 million for the quarter, compared to $154.19 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -9.23 percent. For the current quarter, analysts expect CNS to generate $148.08M in revenue.

Moreover, the firm recently paid out its quarterly dividend on 11/29/2022. Investors who held shares on 11/14/2022 were paid a $0.55 dividend. On an annualized basis, this represents a $2.20 dividend and a 3.00% percent yield. There was an ex-dividend date of 11/11/2022 for this dividend. In terms of dividend payout ratio, CNS is presently at 50.30%.

Cohen & Steers Inc.(CNS) Company Profile

Cohen & Steers, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to institutional investors, including pension funds, endowments, and foundations. It manages separate client-focused equity, fixed income, multi-asset, and commodity portfolios through its subsidiaries. The firm launches and manages equity, fixed income, balanced, and multi-asset mutual funds through its subsidiaries. Through its subsidiaries, it also launches and manages hedge funds. The firm invests in public equity, fixed income, and commodity markets across the globe through its subsidiaries. Through its subsidiaries, it invests in companies operating in the real estate sector, including real estate investment trusts, infrastructure sector, and natural energy resources sector for its equity and fixed income investments. The firm also invests in preferred securities for its fixed income investments through its subsidiaries. Cohen & Steers, Inc. was founded in 1986 and is based in New York, with additional offices in London, United Kingdom; Central, Hong Kong; Tokyo, Japan; and Seattle, Washington.

Tags: CNSCNS stockCohen & Steers Inc.NYSE:CNS

Related Posts

What is YPF Sociedad Anonima’s (NYSE:YPF) current market value? Can you beat the fundamentals?

January 31, 2023

Spirit AeroSystems Holdings Inc. (NYSE:SPR): A Fundamentally Weighted Stock for Long-Term Investors

January 31, 2023

How should investors evaluate Bionano Genomics Inc. (NASDAQ:BNGO)?

January 31, 2023

Reasons why United Parcel Service Inc.’s (NYSE:UPS) fundamentals are futile

January 31, 2023

The shares of Geron Corporation (GERN) have recorded the market capitalization of 1.23B

January 31, 2023

ZIM Integrated Shipping Services Ltd. (ZIM) – it’s time to buy. Check out key Indicators

January 31, 2023
Next Post

A Stock With Stellar Fundamentals? MGP Ingredients Inc. (NASDAQ:MGPI): Is It Right For You?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Despite Cidara Therapeutics Inc. [CDTX]’s great opportunity, the stock is a bit overvalued

3 months ago

Do you still think Establishment Labs Holdings Inc. (NASDAQ:ESTA) is worth a look?

3 months ago

Investor Insight: Imperial Petroleum Inc. (IMPP) Goes Ballistic – Investor Confidence on the Rise

2 months ago

An overview of Redwood Trust Inc.’s (RWT) institutional holdings

1 month ago
logo

Welcome to Fosters Research.
We provide quality information for free in a convenient place and format. You do not need to look for us – the news portal “Fosters Research” meets the reader every morning.

Categories

  • Analyst Opinions
  • Featured
  • Finance
  • Market News
  • Technical Indicators
  • Trending Stocks

Company

  • Home
  • About us
  • Contact

Recent Posts

  • Before Investing In Gevo Inc. (NASDAQ:GEVO), Here Are Some Things To Consider
  • Before You Invest In Emerson Electric Co. (NYSE:EMR), Consider This Metric

Copyright © 2022 fostersresearch

No Result
View All Result
  • Home
  • Analyst Opinions
  • Market News
  • Technical Indicators
  • Trending Stocks

Copyright © 2022 fostersresearch